0 CHECKOUT

The Pharmaceutical Market: Moldova

  • ID: 3233385
  • March 2015
  • Region: Moldova
  • 88 Pages
  • Espicom Business Intelligence Ltd

FEATURED COMPANIES

  • Farmaco (Pharmaco)
  • Gedeon Richter
  • GlaxoSmithKline
  • Novartis (Sandoz)
  • Pfizer
  • Sanofi
  • MORE

Moldova Pharmaceuticals & Healthcare Report:

Given the high level of reliance on out-of-pocket payments, the growth of the Moldova's pharmaceutical market is expected to be shaped by the prevailing economic conditions, both at home and abroad, on account of the importance of remittances to the country's GDP. We expect the market's value to increase at a local currency rate of 6.7%, although this will translate into negative US dollar growth, on the back of a weak leu .

Risk/Reward Rating:

Moldova's Pharmaceutical Risk/Reward Rating (RRR) score, which assesses the country's attractiveness to multinational drugmakers, remains unchanged at 41.8 for Q1. The score places the country second from the bottom in the regional matrix assessing 20 key markets in Central and Eastern Europe. Moldova's risks and rewards are relatively evenly balanced, although both remain considerably lower than the regional averages.

Competitive Landscape:

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Farmaco (Pharmaco)
  • Gedeon Richter
  • GlaxoSmithKline
  • Novartis (Sandoz)
  • Pfizer
  • Sanofi
  • MORE

1. SWOT

2. Industry Forecast

3. Pharmaceutical Market Forecast

- Table: Pharmaceutical Sales, Historical Data And Forecasts (Moldova 2010-2018)

4. Healthcare Market Forecast

- Table: General Government Budget, 2008-2016
- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2010-2018)
- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2010-2018)
- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2010-2018)

5. Prescription Drug Market Forecast

- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Moldova 2010-2018)

6. Patented Drug Market Forecast

- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Moldova 2010-2018)

7. Generic Drug Market Forecast

- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2010-2018)

8. OTC Medicine Market Forecast

- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Moldova 2010-2018)

9. Pharmaceutical Trade Forecast

- Table: Pharmaceutical Trade Data And Forecasts (Moldova 2012-2018)
- Table: Pharmaceutical Trade Data And Forecasts local currency (Moldova 2012-2018)

10. Other Healthcare Data

11. Key Risks To The Forecast Scenario

12. Industry Risk Reward Ratings

13. Central And Eastern Europe Risk/Reward Index

14. Moldova Risk/Reward Ratings

15. Rewards

16. Risks

17. Market Overview

18. Industry Trends And Developments

19. Epidemiology

- Table: 10 Most Frequent Causes of Death, 2012
- Table: Leading Causes Of Morbidity, % Of Total Disease Burden

20. Healthcare Sector

21. Healthcare Financing

- Table: Public Healthcare Expenditure, 2007-2011

22. Primary Care

23. Secondary Care

- Table: Physicians And Hospital Beds In Moldova, 2006-2011

24. Health Insurance

25. Health Insurance Developments

26. Research & Development

27. Regulatory Development

28. Regulatory Developments

29. Intellectual Property Issues

30. Marketing Authorisation

31. Advertising

32. Counterfeit Pharmaceuticals

33. Pricing Regime

34. Reimbursement Regime

35. International Trade Agreements

36. Competitive Landscape

37. Domestic Industry

38. Foreign Industry

39. Recent Pharmaceutical Industry Developments

40. Pharmaceutical Distribution

41. Pharmaceutical Retail

42. Company Profile

- Farmaco (Pharmaco)
- Top Pharm
- Gedeon Richter
- GlaxoSmithKline
- Novartis (Sandoz)
- Sanofi
- Pfizer

43. Demographic Forecast

- Table: Moldova's Population By Age Group, 1990-2020 ('000)
- Table: Moldova's Population By Age Group, 1990-2020 (% Of Total)
- Table: Moldova's Key Population Ratios, 1990-2020
- Table: Moldova's Urban And Rural Population, 1990-2020

44. Glossary

45. Methodology

46. Pharmaceutical Expenditure Forecast Model

47. Healthcare Expenditure Forecast Model

48. Notes On Methodology

49. Risk/Reward Ratings Methodology

50. Ratings Overview

- Table: Pharmaceutical Risk/Reward Ratings Indicators

51. Indicator Weightings

Note: Product cover images may vary from those shown

- Farmaco (Pharmaco)
- Gedeon Richter
- GlaxoSmithKline
- Novartis (Sandoz)
- Pfizer
- Sanofi
- Top Pharm

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. Online access is provided for this product. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. Online access is provided for this product. This is an enterprise license, allowing all employees within your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • AbbVie Ltd.
  • Sigma-Aldrich Corporation
  • Bruker Corporation
  • Raumedic AG
  • Ferring Pharmaceuticals B.V.
  • Baxter International Inc.